ASPIRIN AND NICOTINIC ACID AS TWO FACES OF SAME COIN IN THE TREATMENT OF DYSLIPIDEMIA 

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 3

Abstract

Globally cardiovascular diseases are believed to be the no.1 cause of death. According to the current estimates of World Health Organisation, approximately one-third of all deaths (16.7 million people) around the globe resulted from cardiovascular diseases. Eighty percent of these deaths were reported from low and middle income countries. The main intention of writing this review article is that, India being the second most highly populated country characterized by a majority of low and middle income population, the need for an effective treatment for this devastating disease both cost and efficacy wise is most desired. Since a long time, antidislipidemic agent nicotinic acid has been continuously under consideration to tackle the cardiovascular diseases by treating dyslipidemia. But its use has been limited due to its notorious yet harmless side effect of flushing. Now the focus of attention would be to use nicotinic acid by cleverly handling the flush. At this adjuncture the entry of acetyl salicylic acid (Aspirin) has been taken to give the best result. No doubt the major intention to take aspirin (low dose) with the combination of major drug nicotinic acid is to reduce nicotinic acid -induced flushing, but its associated properties or remedies as you may tell are more equally supportive to the very treatment of cardiovascular diseases itself. Hence it may be construed that aspirin and nicotinic acid are nothing but the two sides of the same coin in the treatment of dyslipidemia. Hence the hypothesis “People with heart disease should be on aspirin anyway”. 

Authors and Affiliations

RK Mutahar, BM Dinesh , SB Sateesha , Khalida Khanum

Keywords

Related Articles

SIMULTANEOUS ESTIMATION OF FEXOFENADINE HYDROCHLORIDE AND MONTELUKAST SODIUM IN BULK DRUG AND MARKETED FORMULATION BY RP-HPLC METHOD  

A new simple and precise accurate RP-HPLC method has been developed and validated for simultaneous estimation of Montelukast Sodium and Fexofenadine in tablet formulations. The chromatographic separation was performed in...

ROLE OF VARIOUS OPIOID RECEPTORS IN OPIOID DEPENDENCE AND WITHDRAWAL SYNDROME 

Although dependence liability of opioids is widely recognized, the relative involvement of different opioid receptors mediating physical dependence is not completely known. The present study was aimed to explore the role...

SYNTHESIS, ANTI-BACTERIAL, AND ANTI-FUNGAL ACTIVITIES OF SOME NOVEL N-SUBSTITUTED 2-(4-STYRYLPHENYL)-1H-BENZIMIDAZOLES  

The synthesis of a series of novel substituted benzimidazole derivatives by the condensation of o-phenylenediamine (1) with 4-bromophenoxy acetic acid (2) and subsequent reactions of the benzimidazole with different elec...

PHYSICOCHEMICAL AND PHYTOCHEMICAL INVESTIGATION OF THREE DIFFERENT SPECIES OF CURCUMA RHIZOME 

The Zingiberaceae, the largest family in the Zingerabales, comprises nearly 50 genera and 1000 species and is pantropical concentrated mainly in the old world, chiefly in Indomalaysia. Members of the family yield species...

SILICA SULFURIC ACID CATALYZED MICROWAVE-ASSISTED SYNTHESIS OF SUBSTITUTED BENZOXAZOLES AND THEIR ANTIMICROBIAL ACTIVITY 

Substituted Benzoxazoles were synthesized by using microwave assisted treatment of orthoesters with o-aminophenols in presence of silica sulfuric acid to get the target compound. The structure of the synthesized compoun...

Download PDF file
  • EP ID EP140207
  • DOI -
  • Views 92
  • Downloads 0

How To Cite

RK Mutahar, BM Dinesh, SB Sateesha, Khalida Khanum (2011). ASPIRIN AND NICOTINIC ACID AS TWO FACES OF SAME COIN IN THE TREATMENT OF DYSLIPIDEMIA . International Research Journal of Pharmacy (IRJP), 2(3), 8-15. https://europub.co.uk/articles/-A-140207